• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synthesis and antiviral evaluation of 6'-acylamido-6'-deoxy-α-d-mannoglycerolipids

tetano

Editor, Senior Moderator
Carbohydr Res. 2013 Aug 23;381C:74-82. doi: 10.1016/j.carres.2013.08.010. [Epub ahead of print]
Synthesis and antiviral evaluation of 6'-acylamido-6'-deoxy-α-d-mannoglycerolipids.
Zhang J, Sun Y, Wang W, Zhang X, Li C, Guan H.
Source

Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, PR China.
Abstract

Eight new aminomannoglycerolipids (2a-h) with linear, branched, or aromatic acyl chains were synthesized and evaluated for their anti-influenza A virus (IAV) activity. By comparing six mannosyl donors with different protecting and leaving groups, the critical glycosylation reaction employed mannosyl trichloroacetimidate with 2-O-benzoyl protecting group as the donor to give the glycoside with absolute α-anomeric selectivity. The bioactivity results showed that the branched compound 2g could effectively inhibit IAV multiplication in MDCK cells with IC50 69.9μM.

Copyright ? 2013 Elsevier Ltd. All rights reserved.
KEYWORDS:

Aminoglycoglycerolipid, Glycosylation, Influenza A virus, α-Anomeric selectivity

PMID:
24076433
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24076433
 
Back
Top Bottom